SHUJEN FERNANDEZ: Open Payments
NPI 1912304759 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,416 in 68 payments from 14 companies in 2025. Trend: 2023 $1,471 · 2024 $1,032 · 2025 $1,416
Food & beverage: $1,416
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 7 | $265 |
| ABBVIE INC. | 19 | $235 |
| Janssen Pharmaceuticals, Inc | 9 | $211 |
| E.R. Squibb & Sons, L.L.C. | 6 | $182 |
| Otsuka America Pharmaceutical, Inc. | 9 | $167 |
| Alkermes, Inc. | 5 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $79 |
| Lundbeck LLC | 2 | $55 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
Products named: INGREZZA, VRAYLAR, COBENFY, ABILIFY ASIMTUFII, SPRAVATO, INVEGA SUSTENNA, CAPLYTA, REXULTI.
Industry payments across FL — which companies pay providers there.
